Morningstar

Align Technology Inc ALGN

Morningstar Rating
Unlock
Stock XNAS Rating as of
$249.46 +7.01 (2.89%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Price vs Fair Value

View History
ALGN is trading at a 358% premium.
Price
$249.46
Fair Value
$784.00
Uncertainty
High
1-Star Price
$414.00
5-Star Price
$225.00
Economic Moat
Jmkgz
Capital Allocation
Xzbykfx

Bulls Say, Bears Say

Bulls

Invisalign is likely to win over new doctors and patients as adoption of clear aligners increases and chips away at wire and bracket market share.

Bears

Increasing competition in the clear aligner market could erode Invisalign’s market share over the long term.

Show More

News

View All

Trading Information

Previous Close Price
$242.45
Day Range
$243.80–253.82
52-Week Range
$176.34–335.40
Bid/Ask
$243.88 / $249.49
Market Cap
$18.63 Bil
Volume/Avg
881,575 / 784,356

Key Statistics

Price/Earnings (Normalized)
27.38
Price/Sales
4.79
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
2.27%

Company Profile

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Core
Total Number of Employees
21,805
Website
https://www.aligntech.com

Competitors

Valuation

View More
Metric
ALGN
STMN
XRAY
Price/Earnings (Normalized)
 27.3841.6714.41
Price/Book Value
 4.9610.861.75
Price/Sales
 4.798.671.42
Price/Cash Flow
 22.6832.3812.32
Price/Earnings
ALGN
STMN
XRAY

Financial Strength

Metric
ALGN
STMN
XRAY
Quick Ratio
 0.981.310.66
Current Ratio
 1.182.111.33
Interest Coverage
 —9.53−0.68
Quick Ratio
ALGN
STMN
XRAY

Profitability

Metric
ALGN
STMN
XRAY
Return on Assets (Normalized)
 11.85%13.75%2.66%
Return on Equity (Normalized)
 19.67%24.67%5.78%
Return on Invested Capital (Normalized)
 18.68%18.85%4.56%
Return on Assets
ALGN
STMN
XRAY

Medical Instruments & Supplies Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
PfllmzgsdXlhqg$172.8 Bil
 Becton Dickinson & Co
BDX
TnxjmxdcGqbdwbt$68.6 Bil
 Alcon Inc
ALC
RcnmjltPpqtphn$48.6 Bil
 ResMed Inc
RMD
PmlkbljqhSgqwwpm$35.6 Bil
 Coloplast AS ADR
CLPBY
XrthxgzxyPxgm$29.1 Bil
 West Pharmaceutical Services Inc
WST
FsvyhtlgXkjs$22.3 Bil
 The Cooper Companies Inc
COO
NxtmqvyjVkxrpw$21.8 Bil
 Baxter International Inc
BAX
HwnrfsvvtWsxqfx$19.7 Bil
 Hologic Inc
HOLX
LpcfnhfZxgqv$18.6 Bil

Sponsor Center